Literature DB >> 34207756

A Multidisciplinary Approach to Coronavirus Disease (COVID-19).

Aliye Gediz Erturk1, Arzu Sahin2, Ebru Bati Ay3, Emel Pelit4, Emine Bagdatli1, Irem Kulu5, Melek Gul6, Seda Mesci7, Serpil Eryilmaz8, Sirin Oba Ilter9, Tuba Yildirim10.   

Abstract

Since December 2019, humanity has faced an important global threat. Many studies have been published on the origin, structure, and mechanism of action of the SARS-CoV-2 virus and the treatment of its disease. The priority of scientists all over the world has been to direct their time to research this subject. In this review, we highlight chemical studies and therapeutic approaches to overcome COVID-19 with seven different sections. These sections are the structure and mechanism of action of SARS-CoV-2, immunotherapy and vaccine, computer-aided drug design, repurposing therapeutics for COVID-19, synthesis of new molecular structures against COVID-19, food safety/security and functional food components, and potential natural products against COVID-19. In this work, we aimed to screen all the newly synthesized compounds, repurposing chemicals covering antiviral, anti-inflammatory, antibacterial, antiparasitic, anticancer, antipsychotic, and antihistamine compounds against COVID-19. We also highlight computer-aided approaches to develop an anti-COVID-19 molecule. We explain that some phytochemicals and dietary supplements have been identified as antiviral bioproducts, which have almost been successfully tested against COVID-19. In addition, we present immunotherapy types, targets, immunotherapy and inflammation/mutations of the virus, immune response, and vaccine issues.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; cytokine storm; dietary supplements; immunotherapy; in-silico research; natural products; repurposing drugs; small drugs; vaccine development

Year:  2021        PMID: 34207756     DOI: 10.3390/molecules26123526

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  2 in total

1.  Epidemiologic characteristics of SARS-CoV-2 in Wuhan, other regions of China, and globally based on data gathered from January 2020 to February 2021.

Authors:  Song Fengjiao; Li Xiaodong; Li Jian; Liu Hui
Journal:  Medicine (Baltimore)       Date:  2022-08-12       Impact factor: 1.817

2.  Microbiological screening tests for SARS-CoV-2 in the first hour since the hospital admission: A reliable tool for enhancing the safety of pediatric care.

Authors:  Giuseppe Vetrugno; Simone Grassi; Francesco Clemente; Francesca Cazzato; Vittoria Rossi; Vincenzo M Grassi; Danilo Buonsenso; Laura Filograna; Maurizio Sanguinetti; Martina Focardi; Piero Valentini; Al Ozonoff; Vilma Pinchi; Antonio Oliva
Journal:  Front Pediatr       Date:  2022-09-06       Impact factor: 3.569

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.